Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency
FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats
FGF2 shows therapeutic effects in Alzheimer's disease animal model via suppressing PI3K/Akt mediated ER stress
FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence
FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats
FGF23-regulated production of fetuin-A (AHSG) in osteocytes (vol 83, pg 35, 2016)
FGF21(L~(59)R)突变体基因工程菌发酵表达条件的优化
FGF21对糖尿病Beagle犬降糖作用的研究
FGF20原核表达载体构建及在大肠杆菌中优化表达
FGF21与奶牛隐性酮病血清BHBA相关性分析
FGF23与骨代谢关系的研究进展
FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity
FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice
FGF2基因真核表达载体构建及其在骨髓间充质干细胞中的表达
FGF21的生物学功能及临床研究进展
FGF23 and Klotho: The new cornerstones of phosphate/calcium metabolism
FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders
FGF21: A novel prospect for the treatment of metabolic diseases
FGF21 reloaded: challenges of a rapidly growing field
FGF21 Is Increased by Inflammatory Stimuli and Protects Leptin-Deficient ob/ob Mice from the Toxicity of Sepsis
FGF21 regulates PGC-1 alpha and browning of white adipose tissues in adaptive thermogenesis
FGF23 Regulation of Phosphorus Homeostasis Is Dependent on PTH
FGF2 induces RANKL gene expression as well as IL1 beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells
FGF23 and PTH-double agents at the heart of CKD
FGF21 Promotes Endothelial Cell Angiogenesis through a Dynamin-2 and Rab5 Dependent Pathway
FGF23 production by osteocytes
FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells
FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/beta-Klotho Bispecific Protein
FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results
FGF23 Beyond Mineral Metabolism: A Bridge to Cardiovascular Disease
FGF23 in Type 2 Diabetic Patients: Relationship With Bone Metabolism and Vascular Disease
FGF21 and the Second Coming of PPAR gamma
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
FGF21 Takes a Fat Bite
FGF21-based pharmacotherapy - potential utility for metabolic disorders
FGF21: A missing link in the biology of fasting
FGF21 is an Akt-regulated myokine
FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity
FGF21 induces PGC-1 alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia
FGF23/Klotho axis: Phosphorus, mineral metabolism and beyond
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?
FGF23 is a hormone-regulating phosphate metabolism - Unique biological characteristics of FGF23
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
FGF23: a key player in mineral and bone disorder in CKD
FGF2 signaling pathway components in tissues of the posterior eye sector in the adult newt Pleurodeles waltl
FGF2-heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities
FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease
FGF2 Sustains NANOG and Switches the Outcome of BMP4-Induced Human Embryonic Stem Cell Differentiation
FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy